(Q39371580)

English

Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Petri Lehenkari

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

4

object named as

Y Soini

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

object named as

M Kaakinen

8

0 references

author name string

P Kuvaja

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S Hulkkonen

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

I Pasanen

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

S Lehtonen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A Talvensaari-Mattila

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

P Pääkkö

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

H Autio-Harmainen

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

T Hurskainen

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

T Turpeenniemi-Hujanen

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

23 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

318

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1094-1103

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

How matrix metalloproteinases regulate cell behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

TIMP-1 as a tumor marker in breast cancer--an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

The absence of immunoreactivity for tissue inhibitor of metalloproteinase-1 (TIMP-1), but not for TIMP-2, protein is associated with a favorable prognosis in aggressive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Stromal myofibroblasts are drivers of invasive cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Osteoblast recruitment from stem cells does not decrease by age at late adulthood

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

mRNA expressions of TIMP-1, -2, and -3 and 92-KD type IV collagenase in early human placenta and decidual membrane as studied by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Differential expression of collagen types XVIII/endostatin and XV in normal, keratoconus, and scarred human corneas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Trafficking and function of the tetraspanin CD63.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2012.03.009

7 January 2021

Identifiers

10.1016/J.YEXCR.2012.03.009

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

release_mtxr77iogrbmtad26lxcusoady

1 reference

https://api.fatcat.wiki/v0/release/mtxr77iogrbmtad26lxcusoady

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39371580&oldid=1842958918"